drugset / Trial / NCT00321347

Intravenous (IV) Lidocaine for Opioid-refractory Pain

NCT00321347

RandomizedParallel-groupDouble-blindTreatment

Summary

Opioid medicines, like morphine, are the main treatment for severe cancer pain. Unfortunately, some patients suffer severe pain despite high doses of opioids. We hypothesize that intravenous lidocaine can quickly and effectively treat this kind of opioid-refractory pain.

Timeline

Start
2006-05
Primary completion
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified Intravenous

Indications